Back to
STATE STREET CORP
ALXN9 quarters
Position history for
STATE STREET CORP's holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, State Street held 10,033,808 shares of ALXN (Alexion Pharmaceuticals), worth $1.8B. State Street's 13F filings listed ALXN from Q3 2019 to Q2 2021, 8 quarterly filings. ALXN was 0.1% of State Street's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$1.1B
Total Shares Change
-10.9M
Quarter-by-Quarter History
Other major holders of ALXN: FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC